Abstract: A see through apparatus receives a paper document. The see through apparatus includes a first scanning element, a second scanning element, and a processor coupled to the first scanning element and the second scanning element. Each of the first and second scanning elements illuminate a respective side of the paper document while the other scanning element captures an image. The processor detects kinematic artifacts on the paper document and determines that the paper document is fraudulent based on the detected kinematic artifacts. The processor also detects an alignment feature from the image capture from the first image or the second image, and determines that the document is not aligned based on the detected alignment feature.

Abstract: A therapeutic treatment kit includes a container for holding a plurality of compartmentalized therapeutic dispensers. Each of the therapeutic dispensers includes a plurality of vials of antigens, and a plurality of containers of supplements disposed in compartments, each of the compartments labeled with the name of the supplement. A compartment is also provided for containing applicators or the antigens, such that an individual can extract the antigen from the vial in a single dose; and para instructions associated with a therapeutic program for utilizing the vials of antigens and the supplements in accordance with a therapeutic program that is predefined. The construction of the kit, including the dosages of the antigen, the types of antigens and the supplements all associated with a particular therapeutic program.

Abstract: A method for initiating a telemedicine conference on a mobile device is provided. The method comprises receiving diagnostic test results in response to a diagnostic test, determining if the diagnostic test results include a positive result, storing the diagnostic test results on a server disposed on a network, presenting, if the diagnostic test results are positive, a telemedicine initiation option on a screen of the mobile device, determining whether the telemedicine initiation option is selected, sending the diagnostic test results from the server to the telemedicine provider, sending additional medical history information to the telemedicine provider, and initiating a telemedicine conference with the telemedicine provider. Some of these aspects also provide healthcare providers the ability to electronically send prescriptions and provide users the ability to use a mobile application to send prescriptions to pharmacies to be filled.

Abstract: A method is provided for interacting with audience members in an event, each of the potential attendees having available thereto a unique identifier. The method comprises creating, for an attendee, a unique ID (UID) on a mobile wireless device (MWD) by the steps of inputting to the MWD one of the unique identifiers, combining the obtained unique identifier with a UID time stamp at the time of creation of the UID; receiving with a server on a first wireless channel communications from the MWD; registering the UID at the physical location of the event; generating a visual query; displaying on the MWD response indicators; receiving at the server from the registered attendee a response, to the query over the first wireless channel; and storing in a database on the server the received response in association with the displayed query.

Abstract: A method for generating a treatment plan in response to medical test results is provided. The method comprises requesting point-of-care (POC) services from a mobile POC unit, receiving at a server confirmation of delivery of POC services to a patient, receiving at the server one or more test results as a result of operation of a medical testing device used in the POC services, wherein the one or more test results includes a determination of the efficacy and dosage level of a medication, generating at the server an updated digital patient record reflecting the one or more test results, and transmitting by the server to a medical entity a treatment plan based on the efficacy and dosage level determined for the medication, wherein the treatment plan is a dosage regimen for the medication.

Abstract: A system and method are provided for collection and testing of a biologic sample in a self-diagnostic test. The system and method comprise collecting by a user of a testing device a biologic sample for use with the testing device, assigning correlative values as test results, and receiving the test results at a server disposed on a network. Some aspects include a mobile application operating on a mobile device with which the user interacts. These aspects allow advertisements and other messages to be presented to the user through the mobile application. Some aspects present different messages to the user based on the type of self-diagnostic test the user is conducting.

Abstract: A system and method are provided for collection and testing of a biologic sample. The system and method comprise collecting by a user of a testing device a biologic sample for use with the testing device, assigning correlative values as test results, and receiving the test results at a server disposed on a network. Some aspects further include presenting advertisements and other messages to users through a mobile application operating on a mobile device. These aspects take into account the results of the self-diagnostic test and present different advertisements to the user based on the results of the test.

Abstract: A method for a microfluidic testing device includes pumping a portion of a biologic sample into each of a first plurality of parallel pathways from the first reservoir using a micro-pump, applying a separate treatment agent of the plurality of treatment agents within each of the first plurality of parallel pathways to the portion of the biologic sample within the parallel pathway, pumping a second portion of the biologic sample into a selected second parallel pathway associated with a determined treatment agent of a second plurality of parallel pathways from the first reservoir using a second micro-pump, applying the determined treatment agent at a plurality of different dosage levels within the selected second parallel pathway to the second portion of the biologic sample within the selected second parallel pathway, and determining a dosage level of the plurality of different dosage levels of the determined treatment agent providing the treatment efficacy.

Abstract: A method for image analysis of medical test results, comprising receiving, at a server, information from a mobile device regarding test results from a test performed using a testing device, wherein the testing device includes an alignment target disposed on the testing device and a plurality of immunoassay test strips, receiving at the server an image of the testing device from the mobile device, determining by the server RGB values for a plurality of pixels of the image, normalizing by the server the RGB values into a single value, comparing by the server the single value to a control value stored on the server, and providing by the server a risk indicator, wherein the risk indicator indicates a likelihood of a presence of a medical condition.

Abstract: A method for creating a consolidated compound for delivering an immunomodulatory and imiquimod to a patient, comprising diluting immunomodulator extract to a desired dilution by transferring a desired quantity of the concentrated immunomodulator to an associated sterile container, the associated sterile container having a defined volume of diluted immunomodulator after dilution thereof, providing a viscous encapsulation material, selecting a prescribed amount of concentrated immunomodulator, the prescribed amount defined as that amount of the diluted immunomodulator extract required to provide a number of doses equal to the number of dispensable increments from the container containing the viscous encapsulation material, introducing the selected amount of each of the diluted immunomodulator extract into the viscous encapsulation material, introducing an amount of imiquimod into the viscous encapsulation material, and mixing the introduced amount of each of the diluted immunomodulator extracts and the introduc

Abstract: A method for collection and dissemination of biologic data, comprising collecting at least one biologic sample by a testing device including thereon an alignment target and including a plurality of immunoassay test strips, wherein the at least one biologic sample contacts a sample pad on at least one of the plurality of immunoassay test strips, assigning correlative values as test results, wherein each test performed on the biologic sample is assigned a different correlative value, receiving the test results at a server disposed on a network, wherein the server has configured thereon a database, assigning a unique identification to the biologic sample, storing the unique identification in the database, storing the test results in the database in association with the unique identification of the biologic sample, and providing access to the database to healthcare organizations for analysis of the test results.

Abstract: A method for delivering an immunomodulator to a patient includes providing a bottle of concentrated immunomodulator extract; progressively diluting the antigen extract in sterile bottles; selecting a prescribed amount from a desired one of the dilution bottles; providing a viscous encapsulation material that is able to introduce antigens contained therein through the skin of a patient; introducing one or more doses of the selected prescribed amount of diluted immunomodulator into the viscous encapsulation material; disposing a prescribed amount of viscous encapsulation material containing the introduced diluted immunomodulator therein within a container that is able to dispense such viscous encapsulation material containing the introduced diluted immunomodulator; dispensing from the container the amount of viscous encapsulation material containing the diluted immunomodulator in an amount equal to a single dose; and applying the dispensed viscous encapsulation material containing the introduced diluted immunom

Abstract: A method of signaling a medical response action comprises receiving a biofluidic input from a client or application, by a logical testing unit, wherein the logical testing unit comprising a testing display and a persistent testing mechanism, further wherein the persistent testing mechanism comprising one or more analogical data processors, generating one or more logical results from the processing of biofluidic data from the biofluidic input, displaying, on the testing display of the logical testing unit, the one or more logical results, capturing the logical indicators on the testing display with a mobile computing unit, generating, by the mobile computing unit, a pixelated result and an action result, displaying, on the mobile display, the pixelated result and action result, responsive to a signaling input from the client or application, the mobile computing unit processes, by one or more processors, the signaling input and generating an action response packet.

Abstract: An artificial intelligence response system comprises a centralized system having associated therewith a trained database, a tends engine, and a plurality of patient records, a plurality of interconnected entities connected over a network to the centralized system, and a voice-activated assistant device connected over the network to the centralized system and to the interconnected entities, the voice-activated assistant device including a memory operatively coupled to a processor, wherein the processor is configured to receive medical information pertaining to a patient's health from the centralized system, request a treatment regimen for the patient from the centralized system, receive a voice command from a medical professional to retrieve additional medical information, request additional medical information in response to the voice command, and request one or more actions related to treating a patient.

Abstract: A method for providing diagnostic test results is provided. The method comprises providing a software application to be stored on a mobile device, the mobile device having a camera and a viewing screen, initiating operation of the camera, aligning the camera with a visual trigger associated with the diagnostic test, capturing an image of the diagnostic test, sending the image to a server, creating a pixel value array from the pixel values in the image, providing the pixel value array as inputs in a trained neural network, and providing either a positive or negative result from the trained neural network in response to the pixel value array.

Abstract: A method of signaling a medical response action comprises receiving a biofluidic input from a client or application, by a logical testing unit, wherein the logical testing unit comprising a testing display and a persistent testing mechanism, further wherein the persistent testing mechanism comprising one or more analogical data processors, generating one or more logical results from the processing of biofluidic data from the biofluidic input, displaying, on the testing display of the logical testing unit, the one or more logical results, capturing the logical indicators on the testing display with a mobile computing unit, generating, by the mobile computing unit, a pixelated result and an action result, displaying, on the mobile display, the pixelated result and action result, responsive to a signaling input from the client or application, the mobile computing unit processes, by one or more processors, the signaling input and generating an action response packet.

Abstract: A method for image processing medical self-test results receives a digital image of a self-test result generated by a self-test device. The digital image is processed using generalized curve field transforms to extract relevant geometrical features of the digital image to create a transformed image that is not distorted by distortions of the digital image. The transformed image is displayed for use in a medical diagnosis.

Abstract: A method is provided for interacting with audience members in an event, each of the potential attendees having available thereto a unique identifier. The method comprises creating, for an attendee, a unique ID (UID) on a mobile wireless device (MWD) by the steps of inputting to the MWD one of the unique identifiers, combining the obtained unique identifier with a UID time stamp at the time of creation of the UID; receiving with a server on a first wireless channel communications from the MWD; registering the UID at the physical location of the event; generating a visual query; displaying on the MWD response indicators; receiving at the server from the registered attendee a response, to the query over the first wireless channel; and storing in a database on the server the received response in association with the displayed query.

Abstract: A method for delivering allergens to a pharmacist in a pre-diluted kit form, comprising providing a bulk container of base concentrate antigen containing at least one antigen at a predetermined concentrated level, creating a sequential and more diluted sequence of antigens, providing a plurality of end-use sealable containers that can receive a finite end amount of diluted antigens, dispensing from each of sequential bulk containers a finite end amount of diluted antigens into one of the plurality of end-use sealable containers, wherein the end-use seal containers filled from each of the sequential bulk containers comprises a group of end-use sealable containers associated with each of the sequential bulk containers, sealing each of the end-use containers after diluted antigens are disposed therein, and disposing a select number of the sealed end-use sealable containers from each of the groups of end-use sealable containers into a container comprising a kit.

Abstract: A see through apparatus receives a paper document. The see through apparatus includes a first scanning element, a second scanning element, and a processor coupled to the first scanning element and the second scanning element. Each of the first and second scanning elements illuminate a respective side of the paper document while the other scanning element captures an image. The processor detects kinematic artifacts on the paper document and determines that the paper document is fraudulent based on the detected kinematic artifacts. The processor also detects an alignment feature from the image capture from the first image or the second image, and determines that the document is not aligned based on the detected alignment feature.